Nina Bauer, MilliporeSigma and Lance Holland, bluebird bio - PART I

In this episode, Anthony and Michael talk to Nina Bauer, the Head of Commercial, Gene Editing and Novel Modalities at MilliporeSigma and Lance Holland, Associate Director, External Vector Manufacturing at bluebird bio.

 

The discussion starts with a look at the challenges brought by Covid-19 with regards to finding a new way of working with your CDMO, in particular conducting audits. Anthony's solution? Use GoPros!

 

Nina puts a question to the group around recruiting diverse talent. With a major talent gap across our industry, this surely has to have many benefits?

 

The conversation flowed so well that we ran out of time, keep your eye out for part II of this conversation coming soon...

 

If you’re not already, don’t forget to sign-up as a Phacilitate member, it’s FREE! Every fortnight you’ll get the latest market intelligence, new ideas and exclusive event offers straight to your inbox.

Join a community with the same goal; to help advance a new standard in healthcare.

https://www.phacilitate.co.uk/membership